-
Greenfield RH. Electric blanket use and breast cancer. Altern Med Alert 2003;6(12):144.
-
Mark JD. Acupuncture and pediatric asthma. Altern Med Alert 2003;6(12):136-139.
-
Coenzyme Q10. Altern Med Alert 2003;6(suppl 12):S1-S2.
-
Greenfield RH. Pollution and cerebrovascular disease. Altern Med Alert 2003;6(12):143-144.
-
Lutz R. Capsaicin and neuropathic pain. Altern Med Alert 2003;6(12):139-143.
-
O'Mathuna DP. Coenzyme Q10 for neurological diseases. Altern Med Alert 2003;6(12):133-136.
-
-
To improve patient survival, the emergency physician (EP) must be knowledgeable about current concepts and controversies in the management of patients in shock. No longer can one simply rely on the presence of traditional clinical markers of shock to make the diagnosis. New and innovative monitoring techniques, as well as continually evolving treatment algorithms, are at the forefront of shock research. This article will educate and update the EP on current and future trends in the management of patients in shock. Equipped with this information, the EP more effectively can identify patients in shock, administer the latest evidence-based treatment, and ultimately improve patient outcome.
-
Reversing Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) is a prospective, randomized, controlled trial assessing the effectiveness of an intensive or aggressive lipid-lowering approach
(atorvastatin 80 mg) to a moderate one (pravastatin 40 mg).
-
In the Valsartan in Acute Myocardial Infarction Trial (VALIANT) the angiotensin II receptor blocker (ARB) valsartan (V) was evaluated in 14,703 high-risk acute MI patients to determine its efficacy and safety
profile compared to the ACE inhibitor captopril (C).